Researchers are saying that, from an infection control perspective, C. auris acts more like a multidrug-resistant, healthcare-associated bacteria than like a typical yeast, according to an article on the MedPage website.
"It is a new bug using old tricks mastered by some well-known, multidrug resistant organisms," they said.
Identifying, treating, and preventing Candida auris is a challenge facing more and more healthcare settings.
Findings presented at the 2019 ASM Microbe meeting in San Francisco by researchers from the Centers for Disease Control and Prevention found that patients with C. auris appear to "shed" the pathogen from their skin into their environment, which could potentially play a factor in transmission.
Wider View: Planning LED Upgrades Across a Healthcare Portfolio
Cone Health Plans Hospital in Forsyth County of North Carolina
Carvel Autism Health to Open New Therapy Clinic in Altoona, Iowa
Cleanliness in Hospitals: Clinical Priority and Community Perception
Dana-Farber Receives $50M Gift for Planned Cancer Hospital